HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Botanee Bio-Technology (300957.CH)-The Success of WINONA Cannot Cover up the Concerns on the Outlook

Pre-IPO Beijing Evercare Medical Technology Group - The Outlook May Not Be Optimistic

Bloomage Biotechnology (688363.CH) Vs Imeik Technology (300896.CH) - The Logic and the Outlook

Industry Report - Insights on China Medical Beauty Industry

Jiangsu Hengrui Medicine (600276.CH) - Insights on Recent Pullback and Future Business Prospects

Bloomage Biotechnology (688363.CH) - Accelerated Growth with the Approval of New Regulation

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Equity Bottom-Up

Bloomage Biotechnology  Lt / Equity Bottom-Up

<p>As a kind of medicine with clinical value, hyaluronic acid has gradually entered people's life. The release of policy about the food-grade hyaluronic acid marked the further opening of China's hyaluronic acid food market. As the world's largest supplier of hyaluronic acid raw material, <a href="https://www.smartkarma.com/entities/bloomage-biotechnology-corporation-a" target="_blank" data-smartkarma-citation="entities:30390:1" rel="noopener">Bloomage Biotechnology Corporation-A (688363 CH)</a> is very clear that this could be the future trend and plans to fully expand the functional food containing hyaluronic acid, which would be one of key drivers of future business growth. This insight mainly analyzed the logic behind this strategy and the potential challenges of the business.</p>

As a kind of medicine with clinical value, hyaluronic acid has gradually entered people's life. The release of policy about the food-grade hyaluronic acid marked the further opening of China's hyaluronic acid food market. As the world's largest supplier of hyaluronic acid raw material, Bloomage Biotechnology Corporation-A (688363 CH) is very clear that this could be the future trend and plans to fully expand the functional food containing hyaluronic acid, which would be one of key drivers of future business growth. This insight mainly analyzed the logic behind this strategy and the potential challenges of the business.

Imeik Technology Development C (300896 CH)

Bloomage Biotechnology (688363.CH) - Opportunities Coexist with Challenges